Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Apr 20 2020

Full Issue

Antibody Testing Rollout Is Also Riddled With Flaws: Inaccurate Results, Shortages And Doctor Mishandling

The antibody tests are crucial to reopening the country, but they come with many of the same flaws as the early virus tests. Complicating matters, the FDA approved a wide range of tests to get them to the marketplace faster. But that means there's a whole lot of inaccurate tests out there. Meanwhile, viral testing hiccups and shortages continue.

The New York Times: Covid-19 Antibody Test, Seen As Key To Reopening Country, Does Not Yet Deliver

A law firm in Scottsdale, Ariz., tested employees who hoped, with the prick of a finger, to learn if they might be immune. In Laredo, Texas, community leaders secured 20,000 of the new tests to gauge how many residents had been infected. In Chicago, a hospital screened firefighters to help determine whether they could safely stay on the job. In recent weeks, the United States has seen the first rollout of blood tests for coronavirus antibodies, widely heralded as crucial tools to assess the reach of the pandemic in the United States, restart the economy and reintegrate society. (Eder, Twohey and Mandavilli, 4/19)

The Washington Post: FDA Did Not Review Many Coronavirus Antibody Tests Flooding The Market

The Food and Drug Administration, criticized for slowness in authorizing tests to detect coronavirus infections, has taken a strikingly different approach to antibody tests, allowing more than 90 on the market without prior review, including some marketed fraudulently and of dubious quality, according to testing experts and the agency itself. Antibody, or serological, tests are designed to identify people who may have overcome covid-19, including those who had no symptoms, and developed an immune response. They are not designed to detect active infections. (McGinley, 4/19)

Politico: Cuomo Says State To Test Thousands For Covid-19 Antibodies

New York will begin testing thousands of residents this week for Covid-19 antibodies as the state moves to reopen the economy in the coming weeks and months, Gov. Andrew Cuomo said Sunday. With data suggesting the coronavirus has passed its apex in New York, Cuomo said health officials will begin conducting an initial 2,000 antibody tests per day — or 14,000 a week — on a random sample of New Yorkers in addition to its diagnostic testing for the virus. (Young, 4/19)

The Wall Street Journal: To Get Back To Work, Companies Seek Coronavirus Tests For Workers

Companies from Amazon.com Inc. to General Motors Co. are exploring ways to test their employees for Covid-19 before they come in to work. Regular tests for workers could keep exposure to sick employees to a minimum and boost employees’ confidence about coming back to work, corporate medical advisers and human-resources executives say. Yet companies face hurdles in rapidly building testing capacity. For one, tests remain tough to obtain in large quantities, those people say, and the practice raises potential issues of privacy and liability. (Krouse, 4/20)

Los Angeles Times: This Bay Area Town Is Among The First To Offer Coronavirus Testing To Every Resident 

The remote Bay Area town of Bolinas is among the first communities in the world to attempt to test all of its residents for the novel coronavirus. Bolinas, population 1,600, will offer free tests Monday through Thursday to residents 4 years and older up, according to a statement from UC San Francisco, whose staffers will administer the tests. (Newberry, 4/19)

ABC News: Coronavirus Testing Only Part Of The Solution To Reopen US: Dr. Deborah Birx

While acknowledging the importance of testing, Dr. Deborah Birx, the White House coronavirus response coordinator, said Sunday that it is only part of the solution to reopen the United States amid the coronavirus pandemic. "One of those critical -- critical -- legs of the stool is testing," she said on ABC’s "This Week" Sunday, but added that monitoring cases and expanding testing are the other two elements. (Arnholz, 4/19)

And testing is only one part of the steps needed to get the country back to normal —

NBC News: 'Army' Of Contact Tracers Will Be Needed In Coronavirus Fight. Experts Say That Could Cost Billions.

With data continuing to suggest New York is "flattening the curve" in the spread of the coronavirus, Gov. Andrew Cuomo said this week that the next phase in the battle for his state and others is on the horizon: contact tracing.But it will come at a hefty cost. The labor-intensive commitment involves identifying those who have tested positive for COVID-19, the disease caused by the coronavirus, and interviewing them to find out where they have gone and whom they’ve come in contact with, an effort that has been effective in controlling other outbreaks, including tuberculosis and SARS. (Ortiz, 4/17)

New Orleans Times-Picayune: Meet The 'contact Tracers': Group Of Workers Vital To Prevent Coronavirus Resurgence In Louisiana 

When a strange new virus begins spreading through a community, state and local health departments know who to call: The contact tracers. They are the men and women who meticulously track down the friends, family and colleagues of infected people to warn them they’re in danger and urge them to quarantine. (Sledge, 4/18)

CBS News: On The Trail Of COVID-19: Contact Tracing The Virus

When we talk about fighting the COVID-19 virus, we hear a lot about social distancing, self-isolation and vaccines. What's weird is that you don't hear much about another incredibly important tool in fighting epidemics: contact tracing. It means detective work. When somebody tests positive, you ask for the names of anyone they've been in contact with recently. (4/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF